rhIGFBP-3 Completed Phase 2 Trials for Steinert's Disease Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00577577Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1